GENCURE’S OBJECTIVE IS YOUR SUCCESS
When you form a partnership with GenCure, we work with you to develop a plan that carries the project from preclinical studies through clinical phase evaluation, and ultimately to commercialization. We work with teams of technical experts – in-house and among our collaborators – to provide critical services to pioneering researchers and companies developing regenerative medicine products. We tailor our services to fit your needs and provide your team with transparency to support the journey through each phase of development. Our manufacturing areas and processes are designed to facilitate client visibility, affording your team access and knowledge sharing. Our track record in developing industry collaborations sets us apart to provide the support you need to get to clinic. Additionally, GenCure and RoosterBio Inc. have announced our one-of-a-kind partnership for off-the-shelf hMSCs which allows us, as their preferred manufacturing partner, to start with a scalable manufacturing process for RoosterBio’s cGMP-compliant, off-the-shelf hMSCs.
At GenCure we have the ability to develop cGMP-compliant, scalable processes for every phase of development, as well as experience in developing and validating analytical test methods for product characterization and release testing.
FIND OUT MORE.
We have extensive experience in cGMP-compliant manufacturing of both tissue and cell-based products. We have completed the technology transfer of RoosterBio’s hMSCs and all of the quality documentation is ready and prepared to support your regulatory filings.
FIND OUT MORE.
Gencure, a subsidiary of BioBridge Global, offers a variety of ways for you to stay connected with us. You can read our latest industry news here. Or, for the social media enthusiast, the BioBridge family is known as “Connect for Life,” and can be found on Facebook, Twitter, LinkedIn and YouTube.
GENCURE’S NEWEST FACILITIES ARE NOW OPEN!
GenCure is excited to announce the opening of our brand new facilites. Our core resources have expanded to include in-house expertise in stem cell cGMP manufacturing, quality management, compliance, and testing, with the goal of developing new approaches for cell expansion and manufacturing.